期刊文献+

纤维溶解酶原激活物抑制剂-1对大鼠胚肺成纤维细胞的影响 被引量:7

The effect of plasminogen activator inhibitor-1 on embryonic lung fibroblasts from rats
原文传递
导出
摘要 目的 研究纤维溶解酶原激活物抑制剂-1(PAI-1)对大鼠胚肺成纤维细胞增殖、转化及胶原合成的影响,探讨PAI-1在肺纤维化发生中的作用.方法 体外分离培养Wister 待产孕大鼠胚肺成纤维细胞,应用四甲基偶氮唑盐试验观察不同浓度(5、10、20、40、80 μg/L)的PAI-1刺激12、24和48 h后成纤维细胞的增殖率;选用PAI-1最适浓度20 μg/L刺激48和72 h后,细胞免疫化学法检测增殖细胞核抗原(PCNA)的表达;实时PCR法检测α-平滑肌肌动蛋白(α-SMA)、Ⅰ型胶原24和48 h时mRNA表达的变化.结果各浓度PAI-1刺激成纤维细胞后,以20 μg/L 12 h增殖率及吸光度值最高,分别为62.6%和0.573±0.039.在12 h中,不同浓度组较对照组差异有统计学意义(F=111.112,P=0.000),选择20 μg/L为最适浓度.免疫细胞化学法检测20 μg/L PAI-1刺激48、72 h后,PCNA表达的积分吸光度值分别为3685±686和2530±477,较对照组差异有统计学意义(F=7.85,P=0.020).PAI-1刺激成纤维细胞24和48 h后,α-SMA表达上调(230±11)%和(159±9)%,较对照组差异有统计学意义(F=39.92,P=0.000).Ⅰ型胶原表达上调(92±8)%和(65±12)%,差异有统计学意义(F=32.61,P=0.001).结论 PAI-1可以促进成纤维细胞增殖、转化及胶原合成,可能促进肺间质纤维化的发生和发展. Objective To explore the effect of plasminogen activator inhibitor-1 (PAI-1) on the proliferation and conversion of rat embryonic lung fibroblasts and the synthesis of collagen, and therefore to explore the function of PAI-1 in pulmonary fibrosis.Methods The embryonic lung fibroblasts from pregnant Wistar rats were isolated and cultured in vitro. The reproduction rate of fibroblasts at 12 h, 24 h, and 48 h after being stimulated by PAI-1 with different concentrations (5, 10, 20, 40, 80, and 100 μg/L) was measured by MTT assay. After being stimulated by PAI-1 with the most suitable concentration (20 μg/L) for 48 h and 72 h, the expression of proliferating cell nuclear antigen (PCNA) was measured by immunocytochemical technique, and the mRNA expression of α-SMA and type-1 collagen at 24 h and 48 h was measured by real-time PCR. Results PAI-1 with different concentrations stimulated the proliferation of fibroblasts. The highest proliferation rate and absorbance in concentration of 20 μg/L and at 12 h were 62.6% and 0.573±0.039. The comparison of different concentrations showed that the difference was significant(F=111.112,P=0.000). Therefore, 20 μg/L was selected as the most suitable concentration. Using immunocytochemical method, the optical density of PCNA at 48 h and 72 h were 3685±686 and 2530±477 after being stimulated with 20 μg/L PAI-1.The comparison showed significant difference(F=7.85,P=0.02). The expression of α-SMA increased (230±11)% and(159±9)% at 24 h and 48 h after being stimulated with 20 μg/L PAI-1, and the difference was significant(F=39.92, P=0.0003). The expression of type-1 collagen increased(92±8)% and (65±12)%, the difference being significant(F=32.61,P=0.0006). Conclusion PAI-1 can promote the proliferation and conversion of fibroblasts and the synthesis of collagen, which may be involved in the pathogenesis of pulmonary interstitial fibrosis.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2011年第7期500-503,共4页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 河北省自然科学基金(C2009001161)
关键词 成纤维细胞 纤溶酶原激活物抑制物1 细胞增殖 肌动蛋白类 胶原Ⅰ型 Fibroblasts Plasminogen activator inhibitor-1 Cell proliferation Actins Collagen type-Ⅰ
  • 相关文献

参考文献14

  • 1Doubkov6 M, Skhickov6 J. Idiopathic pulmonary fibrosis. VnitrLek, 2005, 51:1375-1384.
  • 2Binder BR, Mihaly J, Praqer GW. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist' s view. Thromb Haemost, 2007, 97:336-342.
  • 3Balsara RD, Ploplis VA. Plasminogen activator inhibitor-1 : the double-edged sword in apoptosis. Thromb Haemost, 2008, 100: 1029-1036.
  • 4Chuang-Tsai S, Sisson TH, Hattori N, et al. Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1. Am J Pathol. 2003. 163:445-452.
  • 5张彦萍,曹书颖,马俊义,王立芹,王保法.博莱霉素致肺纤维化大鼠凝血活性的变化及意义[J].中华结核和呼吸杂志,2005,28(8):541-544. 被引量:10
  • 6Sugimoto H, Mundel TM, Kieran MW, et al. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther, 2006, 5 : 1640-1646.
  • 7Rφmer MU, Larsen L, Offenberg H, et al. Plasminogen activator inhibitor 1 protects fibrosarcoma ceils from etoposide-induced apoptosis through activation of the PI3 K/Akt cell survival pathway. Neoplasia, 2008, 10 : 1083-1091.
  • 8Hu PF, Zhu YW, Zhong W, et al. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells. J Gastroenterol Hepatol, 2008, 23:1917-1925.
  • 9Chen Y, Budd RC, Kelm RJ Jr, et al. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. Arterioseler Thromb Vase Biol, 2006, 26 : 1777-1783.
  • 10Li SH, Gorlatova NV, Lawrence DA, et al. Structural differences between active forms of plasminogen activator inhibitor type 1 revealed by conformationally sensitive ligands. J Biol Chem, 2008, 283 : 18147-18157.

二级参考文献31

  • 1Blanc-Brude OP, Chamber RC, Leoni Pet al. FactorXa is a fibroblast mitogen via binding to effector-cell protease receptor-1 and autocrine release of PDGF. Am J Physiol Cell Physiol, 2001, 281 :c681 -c689.
  • 2Clark JG, Kostal KM, Marino BA. Bleomycin-induced pulmonary fibrosis in hamster. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production. J Clin Invest, 1983, 72: 2082-2091.
  • 3Imokawa S, Sato A, Hayakawa H , et al. Tissue factor expression and fibrin deposition in the lung of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 1997, 156(2pt l) : 631-636.
  • 4Idell S, Gonzalez KK, MacArthur CK, et al. Bronchoalveolar lavage procoagulant activity in bleomycin-induced lung injury in marmosets.Characterization and relationship to fibrin deposition and fibrosis. AmRev Respir Dis, 1987, 136: 124-133.
  • 5iIdell S, Peterson BT, Gonzalez KK, et al. Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleie acid-induced lung injury. Am Rev Respir Dis, 1988,138 : 1282-1294.
  • 6Eitaman DT, McCoy RD, Zheng X, et al. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest,1996, 97 : 232-237.
  • 7Tani K, Ognshi F, Takahashi H, et al. Thrombin stimulates platelet-derived growth factor release by alveolar maerophage in rat. Significance in bleomyein-induced pulmonary fibrosis. J Med Invest, 1997, 44: 59-65.
  • 8Howell DC, Goldsaek NR, Marshall RP, et al. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol, 2001, 159: 1383-1395.
  • 9Kobayashi H, Gabazza EC, Taguehi O, et al. Protein C anticoagulant system in patients with interstitial lung disease. Am J Respirr Crit Care Med, 1998, 157: 1850-1854.
  • 10Selman M, Pardo A. The epithelial/fibroblasfic pathway in the pathogenesis of idiopathic pulmonary fibrosis[J]. Am J Respir Cell Mol Biol,2003 ,29( 3 suppl) :93-96.

共引文献18

同被引文献55

  • 1仇裕丰,王建陵,吴彻.艾灸治疗病毒病机理探讨[J].北京中医,1994,13(5):49-49. 被引量:8
  • 2张彦萍,曹书颖.PAI-1与肺纤维化[J].国外医学(呼吸系统分册),2005,25(5):343-344. 被引量:5
  • 3张彦萍,曹书颖,关继涛,王保法,孟爱宏.博莱霉素致大鼠肺纤维化过程中纤溶酶原激活剂抑制物1活性变化的意义[J].中华结核和呼吸杂志,2005,28(10):727-728. 被引量:3
  • 4陈扬(综述),陆铸今(审校).纤溶酶原激活物抑制剂-1与肺损伤关系的研究进展[J].国际儿科学杂志,2007,34(2):86-89. 被引量:1
  • 5Liu RM. Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis [J]. Antioxid Redox Signal, 2008, 10(2), 303-319.
  • 6Swaisgood CM, French EL, Noga C, et al. The development of bleomycin- induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system [J]. Am J Pathol, 2000, 157(1) : 177-187.
  • 7Senoo T, Hattori N, Tanimoto T, et al.Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis [J]. Thorax, 2010, 65(4):334-340.
  • 8Sijen T, Steiner FA, Thijssen KL, et al. Secondary siRNAs result from unprimed RNA synthesis and form a distinct class [J]. Science, 2007, 315(5809) : 244- 247.
  • 9Sisson TH, Simon RH. The plasminogen activation system in lung disease [J]. Curr Drug Targets, 2007, 8(9): 1016-1029.
  • 10Bchr j idiopathic pulmonary fibrosisL:modem guidelineconcondant diagnostics and innovative treatment Dtsch Med Wochcnscher, 2012. 137 :601-604.

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部